Pharmaceutical intermediates
BDTX-1535 Intermediates
9 pharmaceutical intermediates for BDTX-1535.
About BDTX-1535
- Originator
- Black Diamond Therapeutics Inc
Available intermediates
9 intermediates currently listed for BDTX-1535. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| (E)-4-bromo-N-(4-((3-chloro-2-fluorophenyl)amino)-7-(((1R,5S)-3-methyl-3-azabicyclo[3.1.0]hexan-1-yl)ethynyl)quinazolin-6-yl)but-2-enamide | 2607830-54-4 | / | / |
| 4-((3-chloro-2-fluorophenyl)amino)-6-nitroquinazolin-7-yl trifluoromethanesulfonate | 2607829-90-1 | / | / |
| N4-(3-chloro-2-fluorophenyl)-7-[2-[(1S,5R)-3-methyl-3-azabicyclo[3.1.0]hexan-1-yl]ethynyl]quinazoline-4,6-diamine | 2607831-31-0 | / | / |
| N-(3-chloro-2-fluorophenyl)-7-[2-[(1S,5R)-3-methyl-3-azabicyclo[3.1.0]hexan-1-yl]ethynyl]-6-nitroquinazolin-4-amine | 2607831-30-9 | / | / |
| 7-[2-[(1S,5R)-3-azabicyclo[3.1.0]hexan-1-yl]ethynyl]-N-(3-chloro-2-fluorophenyl)-6-nitroquinazolin-4-amine | 2607832-35-7 | / | / |
| Close 7-[2-(3-azabicyclo[3.1.0]hexan-1-yl)ethynyl]-N-(3-chloro-2-fluorophenyl)-6-nitroquinazolin-4-amine | 2607831-28-5 | / | / |
| tert-butyl 1-((4-((3-chloro-2-fluorophenyl)amino)-6-nitroquinazolin-7-yl)ethynyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate | 2607831-27-4 | / | / |
| racemic tert-butyl rac-1-formyl-3-azabicyclo[3.1.0]hexane-3-carboxylate | 1622903-52-9 | / | / |
| tert-butyl 1-ethynyl-3-azabicyclo[3.1.0]hexane-3-carboxylate | 1936077-76-7 | / | / |
Building toward BDTX-1535?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →